|
 |
||||||||||||
Program Click on the session names to view faculty and talk titles. Download a PDF version of the 2012 program including assigned rooms.* Key: Fascinating Cases for Breakfast Teaching Session Meet the Experts Plenary Oral Abstract Presentations Case Presentations Masters: Simple & Complex Cases * Program may not include abstracts and case presenters who provided information after the publication deadline. Wednesday, April 11, 20126:00 - 8:00 pm
Registration
Thursday, April 12, 20127:00 - 8:25 am
Registration and Continental Breakfast
Chairs: Vuyisile Nkomo, MD, Bernard Iung, MD Presenters: Kevin Greason, MD, Hector Michelena, MD, Neil Moat, MD, Yukikatsu Okada, MD, Lars Svensson, MD Presenters:Sunil Mankad, MD, Helen Thomson, MD, Joseph Maalouf, MD Presenters:Wiley Nifong, MD, Rakesh Suri, MD, Robinson Poffo, MD 8:30 - 8:40 am
Featuring:Jeffrey S. Borer, MD, Maurice E. Sarano, MD, José-Luis Pomar, MD, Gino Gerosa MD, Hartzell Schaff, MD 8:40 - 10:00 am
Co-chairs:Marcia Barbosa, MD, Jeffrey S. Borer, MD, Gino Gerosa, MD, Yukikatsu Okada, MD VHD:The New Epidemy — Phyllis Supino, EdD VHD: The Repair Revolution — Hartzell Schaff, MD VHD: The Percutaneous Revolution — Murat Tuzcu, MD VHD: The Imaging Revolution — Maurice E. Sarano, MD Panel Discussion/Q&A 8:30 - 10:00 am
Presenters:Judy Hung, MD, Patrizio Lancellotti, MD, PhD, Joseph Maalouf, MD Presenters:Tomislav Mihaljevic, MD, Evelio Rodriquez, MD, Clifton Lewis, MD 10:00 - 10:30 am
Break
10:30 - Noon
Co-chairs:Raphael Rosenhek, MD A. Jamil Tajik, MD What is Severe Aortic Stenosis? — David Messika-Zeitoun, MD, PhD Asymptomatic Aortic Stenosis — Blase A. Carabello, MD Low-gradient Severe Aortic Stenosis — Philippe Pibarot, DVM, PhD Surgical Aortic Valve Replacement: Present and Future — Wilson Szeto, MD Percutaneous Aortic Valve Replacement: Present and Future — Raj Makkar, MD Panel Discussion/Q&A Co-chairs:Antonio Maria Calafiore, MD, Uri Elkayam, MD Ischemic MR Surgery — Antonio Maria Calafiore, MD LV Remodeling Surgery — Eugene Grossi, MD LVAD & Valve Regurgitations — Soon Park, MD Ischemic MR Pathophysiology at Rest and with Exercise — Jean-Louis Vanoverschelde, MD, PhD Co-chairs:Adrian Chester, PhD, Gino Gerosa, MD Percutaneous Implantation — Simon P. Hoerstrup, MD, PhD Decellularised Valves — Artur Lichtenberg, MD Use of Adipose Derived Stem Cells — Dan T. Simionescu, PhD Role of Endothelial Cells in Valve Tissue Engineering— Adrian Chester, PhD Co-chairs:Mark Starling MD, Thierry Le Tourneau, MD HTN and AS — Jean Dumesnil, MD Hemodynamics of Regurgitations with Exercise — Luc Pierard, MD, PhD Diagnosis of Valve Disease with High-Fidelity Catheterization — Paul Sorajja, MD Hemodynamics of Aortic Regurgitation — Warren Laskey, MD Paul Grayburn, MD, Joseph Maalouf, MD W. Randolph Chitwood, MD, Leland Siwek, MD, Rakesh Suri, MD Noon - 1:25 pm
Lunch
Industry Symposia -- Supported by Sorin, St. Jude
1:30 - 3:00 pm
Percutaneous AVR Should Be Reserved for Inoperable Patients Pro — Thoralf Sundt, MD Functional Mitral Regurgitation: Best Treatment Pro clip — Ted Feldman, MD Co-chairs:Paul Grayburn, MD, Judy Hung, MD Critical Evaluation of MR by a Core Lab — Elyse Foster, MD Critical Evaluation of AS by a Core Lab — Linda Gillam, MD Critical Evaluation of LV Remodeling by a Core Lab — Jae Oh, MD Co-chairs:Martin Abel, MD, Soon Park, MD Anesthesia for High-Risk TAVI — William Mauermann, MD Anesthesia for Transapical Intervention — Kent Rehfeldt, MD Anesthesia for the Treatment of Functional MR — Nikolaos Skubas, MD Hemodynamic Monitoring During High-Risk Procedures — Amanda J. Rhee, MD Co-Chairs:Michael A. Borger, MD, PhD, W. Randolph Chitwood, MD Which Valve Repair Can Be Thoracoscopic? — James Gammie, MD How to Migrate to Thoracoscopic Mitral and Tricuspid Surgery — Clark Hargrove, MD Ideal Instrumentation for Thoracosopic Surgery — Michael Borger, MD Thoracoscopic Mitral Reoperations — Hugues Jeanmart, MD Sunil Mankad, MD, Hector Michelena, MD, Vuyisile Nkomo, MD Kevin Greason, MD, Jean-François Obadia, MD, Carlos Ruiz, MD Chair:Blase Carabello, MD Progression of Aortic Valve Stenosis is Associated with Bone Remodeling and Secondary Hyperparathyroidism — David Messika- Zeitoun, MD, PhD Antimineralization Treatment Reduces Structural Valve Degeneration: A 15y Follow-up Study in 648 Aortic Bioprostheses — Bart Meuris, MD Relation between Symptoms and Longitudinal Strain in Patients with Aortic Stenosis — David Messika-Zeitoun, MD Outcome of Conventional Aortic Valve Replacement in the Era of Transcatheter Aortic Valve Implantation — Arnaud Van Linden, MD Accuracy of New EuroSCORE II in Patients Undergoing Transcatheter Aortic Valve Implantation — Arnaud Van Linden, MD Chair:Niki Kantrowitz, MD Non-coronary Sinus Sparing Operation as the Strategy of Choice for Treatment of Ascending Aortic Aneurysm in Bicuspid Aortic Valve: Long-term Results of a Prospective Study — Vera Renier, MD Midterm Follow-up after Aortic Valve Repair: A Single Center Experience — Denise Marin, MD Self Expanding Enable versus Transapical Sapien Aortic Valve Implantations at Midterm — Mirko Doss, MD What If Transfemoral and Transapical Approach are not an Option? Alternative Access in Transcatheter Aortic Valve Implantation — Tine E. Philipsen, MD Single Centre Experience in 203 Patients with Ministernotomy as Approach for Surgery of Aortic Valve and Ascending Aorta: Inversed "J" or "Z" Sternotomy? — Udo Boeken, MD Chair:Jason Lazar, MD Conventional Aortic (AVR) Valve Replacement (AVR) in Nonagenarians at Times of TAVI: Is it Still Justified? — Udo Boeken, MD Long-term Outcome of Aortic Valve Replacement (AVR) with Stentless Valves — Rephael Mohr, MD Assessment of a Transcatheter Heart Valve Prosthesis with Multislice Computed Tomography: In-vitro and In-vivo Imaging Characteristics — Linda M. de Heer, MD The New Aortic Supra-Annular Pericardial Stentless Bioprosthesis: Experimental Assessment and First Clinical Experience — Ravil M. Muratov, MD Determinants of Functional Mitral Regurgitation in Patients with Aortic Stenosis. A Quantitative Prospective Study — Andrea Rossi, MD Chair:Furqan Tejani, MD Prognostic Implication of BNP Levels in Patients who Underwent Surgery for Severe Aortic Regurgitation and Normal Left Ventricular Function — Mariano L. Falconi, MD Aortic Valve and Root Mechanics in Severe Aortic Regurgitation: Volume-based Quantitative Analysis Using Real-time Three-dimensional Transesophageal Echocardiography — Sung-Ji Park, MD, PhD Baseline Left Ventricular End-systolic Dimension Predict Contractile Reserve on Exercise Echocardiography in Moderate to Severe Aortic Regurgitation — Sung-Ji Park, MD, PhD Aortic Valve Repair: Influence of the Ventriculo-Aortic Junction and the Sino-Tubular Junction on the Leaflets Coaptation — Andrea Mangini, MD Chair:Ozgen Dogan, MD Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Pre-Operative Contractility Measurement — Antony Innasimuthu, MD Single Institution Experience with Valve-sparing Root Reimplantation – Raphed Bicuspid Aortic Valve versus Tricuspid Aortic Valve Patients — Prashanth Vallabhajosyul Does Pregnancy Influence the Durability of Human Aortic Valve Substitutes? — Helena J. Heuvelman, MD Pregnancy Outcomes in Women with Aortic Valve Substitutes — Helena J. Heuvelman, MD Direct Aortic Access as a Safe Alternative in Transcatheter Aortic Valve Replacement AVR — Basel Ramlawi, MD 3:00 - 3:30 pm
Break
3:30 - 5:00 pm
Co-chairs:Michael A. Borger, MD, PhD, José-Luis Pomar, MD 2D and 3D Imaging for Valve Repair — Sunil Mankad, MD Who has Severe MR: Who Needs Repair While Asymptomatic? — Maurice E. Sarano, MD Surgical Repair: What is an Advanced Repair Center? — David Adams, MD Robotic Repair: The Holy Grail — Rakesh Suri, MD Percutaneous Innovations: Real Hopes? — Alfredo Trento, MD Panel Discussion/Q&A Co-Chairs: Vuyisile Nkomo, MD, Elijah Nyainda Ogola, MD, Flavio Tarasoutchi, MD Exercising Valve Diseases vs. Coronary Disease — Jeffrey S. Borer, MD Cardiopulmonary Exercise Testing — Thomas Allison, PhD Exercise Testing in AS vs. MR — David Messika-Zeitoun, MD, PhD Supine-Bike Exercise Testing — Luc Pierard, MD, PhD Co-Chairs: Susheel Kodali, MD, Chet Rihal, MD Vascular Complications of TAVI — Kevin Greason, MD Embolization/Displacement of Devices — Geoffrey W. Bergman, MBBS Perforations/Tamponades — Murat Tuzcu, MD Deployment Failure-Time for Surgery? — Arash Salemi, MD Co-Chairs: Susheel Kodali, MD, Chet Rihal, MD Hybrid OR for Apical Approaches to Valve Diseases — Todd Dewey, MD TransAortic vs. TransAxillary vs.TransFemoral — Domenico Mazzitelli, MD Instrumentation for Teamwork — Lars Svensson, MD Salvatore Costa, MD, Rebecca Hahn, MD, Helen Thomson, MD Gregory Fontana, MD, Paul Sorajja, MD, Matthew R. Williams, MD Chair:Blase Carabello, MD A Quantitative Approach to Pulmonary Autograft Remodeling after the Ross Procedure — Andrew D. Wisneski, MD Aortic Valve Calcification by Micro-Computed Tomography Correlates with Aortic Stenosis Severity — Andrew D. Wisneski, MD Impact of Transcatheter Aortic Valve Oversizing on Stress Distribution of Leaflets and Frame: A Finite Element Analysis — Andrew D.Wisneski, MD Insulin Resistance is Associated with Faster Progression of Left Ventricular Hypertrophy in Patients with Aortic Stenosis: A Substudy of the ASTRONOMER Trial — Romain Capoulade, MSc Angiotensin-Receptors Blockers but not Angiotensin-Converting Enzyme Inhibitors Are Associated with Reduced Stenosis Progression and All-Causes Mortality in Patients with Aortic Stenosis — Romain Capoulade, MSc Chair:Niki Kantrowitz, MD Survival after Aortic Valve Replacement in Patients with Severe Aortic Stenosis, Low Gradient despite preserved LV Ejection Fraction — Marie-Annick Clavel, MD Usefulness of Aortic Valve Calcium Scoring in Patients with Aortic Stenosis and Discordant Doppler-Echocardiographic Findings — Marie-Annick Clavel, MD Severe Aortic Stenosis in High Risk Patients: Comparison between TAVI and Surgical AVR — Shuli Silberman, MD Investigating the Genetic Component of Calcific Aortic Valve Stenosis by Sequencing the Whole-Exome of Familial Cases — Solena Le Scouarnec, MD Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Implantation – Myth or Reality? — Arnaud Van Linden, MD Chair:Jason Lazar, MD Systematic Familial Screening Identified a High Frequency of Heritability in Calcific Aortic Valve Disease — Thierry Le Tourneau, MD Reactive Oxygen Species induce DNA Damage Response and Osteogenic Transdifferentiation of Valvular Interstitial Cells in Calcific Aortic Valve Disease — Giovanni Ferrari, MD Quantitative Assessment of Left Ventricular Function by 3D Speckle Tracking Echocardiography in Aortic Stenosis: Feasibility and Reproducibility — Catherine Szymanski, MD Genome-wide Analysis of Altered Gene Expression and Signaling in Calcific Aortic Valve Stenosis — Rami A. Kafa, MD Dimethylarginine Dimethylaminohydrolase-1 Plays as Initiation Protect Factor of Fibrocalcific Aortic Valve Disease — Bin Zhang, MD Chair:Sary Aranki, MD Control of Bleeding Following Modified Bentall Operation — Manju Gupta, MD Ascending Aortic Dimensions: Comparison between Cardiac Magnetic Resonance and Transthoracic Echocardiography in Congenital Aortic Stenosis Patients — Denise van der Linde, MD Aortic Root Assessment Using Perioperative DynaCT Imaging During Transcatheter Aortic Valve Implantation — Arnaud Van Linden, MD Excellent Hemodynamic Behavior of Decellularized Aortic Root Prostheses – A Porcine Model with 6 Month Follow-up — Jesper L. Honge, MD The Impact of Echocardiographic Valve Configuration on Mid-term Durability after Aortic Root Replacement with Reimplantation Technique — Shunsuke Miyahara, MD Chair:Ozgen Dogan, MD Bicuspid Aortic Valves and Rare Copy Number Variants Are Enriched in Early Onset Thoracic Aortic Disease — Siddharth K. Prakash, MD Quantitative Three-Dimensional Analysis of Bicuspid Aortic Valves: A Single Modality Approach for Characterization of Valvular and Proximal Aortic Pathology — Melissa M. Levack, MD The Bicuspid Aortic Valve: A Correlation between Phenotypic Classification of Leaflet Morphology and Valvular Function — Ji-Hyun Kim, MD The Minimally Invasive Aortic Root Replacement: Early and Mid-term Results in 106 Patients — Sergey Leontyev, MD Root Replacement for Excavating Aortic Valve Endocarditis with the Freestyle® Zenograft — Anneliese Heinz, MD Aortic Root Reconstruction for Annuloaortic Ectasia with Aortic Valve Reconstruction using Autologous Pericardium — Shigeyuki Ozaki, MD Friday, April 13, 20127:00 - 8:25 am
Continental breakfast
Co-chairs:Randy Martin, MD, A. Jamil Tajik, MD Presenters:Trevor Fayers, FRACS, Samir Kapadia, MD, Francesco Musumeci, MD, Yutaka Okita, MD, PhD, Flavio Tarasoutchi, MD Chair:Alan Feit, MD Aortic Valve Replacement with and without Coronary Artery Bypass Graft Surgery in Octogenarians: Is it Safe and Feasible? — Nicole J. Abel, MD Historical Trends in Outcomes following Aortic and Mitral Heart Valve Replacement Procedures: A Population-Based Study of 29,582 Medicare Patients from 1997 to 2009 — Kevin L. Ong, MD A New Alternative for Transapical Aortic Valve Implantation: The Symetis ACURATE TA™ Device – Clinical Experience to Date — Joerg Kempfert, MD A Novel Aortic Valve Prosthesis Made of a New Nanocomposite Polymer: Hydrodynamic Assessment — Benyamin Rahmani, MD Is there an Impact on Postoperative Morbidity and Long Term Survival after Minimal Access Aortic Valve Replacement — Sven Lehmann, MD Chair:Jacek Preibisz, MD Minimally Invasive Aortic Valve Replacement (AVR) with Stentless Pericardial Valves (SPV): Three Years Experience — Alberto Repossini, MD Thrombocytopenia after Sorin Freedom Solo Stentless Valve Implantation: Qualitative Analysis of an Epiphenomenon of no Clinical Significance — Jonida Bejko, MD Transapical and Transaortic Native Aortic Valve Resection Using Endovascular Circular Blade — Astarci Parla, MD A Multimarker Study of Degenerative Aortic Valve Disease: Steno-Insufficiency Shows More Indices of Bad Prognosis — Annamaria Vianello, MD, PhD Single Center Midterm Results from the FDA Trial of the St. Jude Medical Trifecta™ Pericardial Aortic Valve Bioprosthesis — Joseph Bavaria, MD Chair:Louis Salciccioli, MD Conventional Aortic Valve Replacement in Octogenarians — A Single Center Experience — Justin D. Roberts, DO Association between Increased ApoB/ApoA-I Ratio and Increased Risk of Structural Deterioration of Bioprosthetic Valves — Haifa Mahjoub, MD Risk Factors for Low Cardiac Output Syndrome after Aortic Valve Replacement — Wilhelm P. Mistiaen, MD Cardiothoracic Surgeons' View on Decision-making in Prosthetic Aortic Valve Selection AVR — Johanna J.M Takkenberg, MD, PhD 1000 Pericardial Valves in Aortic Position During 20 Years: Predictors of Hospital Mortality — Wilhelm P. Mistiaen, MD Chair:Jonathan Marmur, MD Early and Mid-term Survival in High-risk Aortic Valve Replacement and Concomitant Coronary Artery Bypass Grafting Using the 3F Stentless Bioprosthesis — Prity A. Gupta, MD Relationship between Virtual Basal Ring and Ventriculo-arterial Junction in Human Heart: Surgical and Interventional Implications of Aortic Valve Repair, Stentless, Surtureless Valve and TAVI — Andrea Mangini, MD Functional Performance Evaluation of Decellularized Human Aortic Valves for Pediatric Valve Replacement Surgery — David Gale, PhD C-E Perimount Magna Ease or Sorin Freedom Solo in Aortic Position: A Matched Comparison on Prospectively Collected Hemodynamic Data — Michele Gallo, MD Early and Late Outcome Following Aortic Valve Replacement in a Population of Extremely High-risk Elderly Patients — Alberto Repossini, MD Chair:Balendu Vasavada, MD Clinical Outcome of Patients at Low or Intermediate Risk Undergoing Transcatheter Aortic Valve Implantation — Peter Wenaweser, MD Starting a Minimally Invasive Aortic Valve Program: Lessons and Pitfalls in a Two Year Experience — Gwyn Beattie, MD Two Years Experience Heart Team (HT) Approach to Aortic Valve Stenosis: Trans-catheter (TAVI) vs Stentless Minimally Invasive Surgical Techniques — Alberto Repossini, MD Sorin Freedom Solo Valve: A Stentless Bioprosthesis with Cardiopulmonary and Crossclamp Times Shorter than a Stented Valve — Giacomo Bortolussi, MD Early Clinical Benefits of Mini Upper Sternotomy with the Edwards Intuity Valve System versus Conventional Aortic Valve Replacement Surgery — Michael Borger, MD Chair:Warren Laskey, MD Acute Regurgitant Aortic Rheumatic Valvulitis — Muhammad F. Jan, MD Painless Aortic Dissection — Eric R. Fenstad, MD Severe Aortic Regurgitation Three Years After Neonatal Balloon Valvuloplasty for Aortic Stenosis — Joseph Forbess, MD Kommerell Diverticulum Dissection and Aortic Valve Regurgitation — Harry Acquatella, MD Low Output Syndrome Masking Aortic Regurgitation in a Marfan Patient. Usefulness of 3D Echocardiography and Heart Team — Christiano Amarelli, MD Fulminant Aortic Endocarditis with Aorto-Atrial Shunt. 3D Echocardiography Diagnosis and Surgical Approach — Christiano Amarelli, MD Chair: Robert Emery, MD Transcutaneus Aortic Valve Implantation With the CoreValve Device Within a Prior Aortic Prosthesis — Three Case Experience — Jose A. Condado, MD Alternative Therapies in Treating Left Ventricular Outflow Tract Stenosis in Adults — Jacob DeLaRosa, MD Quadricuspid Aortic Valve Plasty Long — Marco Diena, MD Are Patients With No Sinuses Around the Aortic Valve Cusps More Prone to Developing Endocarditis Post Aortic Root Aneurysm Repair? — Maqsood Elahi, MD New Strategy for Aortic Stenosis with Porcelain Aorta in a Dialysis Patient — Isamu Kawase, MD Detection of Prosthetic Aortic Valve Pannus Formation Using Real-Time Three-dimensional Echocardiography (3D-TEE) — Ji-Hyun Kim, MD 8:30 - 10:00 am
Co-chairs:Jeffrey S. Borer, MD, Johan Brink, MD Aortic Regurgitation: Natural History — Jean-Louis Vanoverschelde, MD, PhD Bicuspid Aortic Valve: Natural History — Hector Michelena, MD Aortic Regurgitation Repair: When and How Durable? — Gebrine El-Khoury, MD Minimally Invasive Approach to Aortic Valve Repair and Replacement — Eric E. Roselli, MD Ascending Aortic Repair: Best Approach — Thoralf Sundt, MD Panel Discussion/Q&A Co-Chairs:Uri Elkayam, MD, Maurice E. Sarano, MD Familial MVP — Bernard Iung, MD MVP Genetics: Typical and Atypical — Thierry Le Tourneau, MD 3D Physiology of MVP — Maurice E. Sarano, MD Cardiac Hormonal Physiology in MVP — Rodolfo Pizarro, MD Co-Chairs: Igor Palacios, MD, Carlos Ruiz, MD New Aortic Prosthetic Devices — Michael A. Borger, MD Mitral Prostheses? — Georg Lutter, MD New Devices to Minimize Vascular Complications — Murat Tuzcu, MD Apical Percutaneous Approaches to Everything — Carlos Ruiz, MD Co-Chairs: Didier Loulmet, MD, Robinson Poffo, MD The Learning Curve — W. Randolph Chitwood, MD Functional Mitral Valve Prolapse — Aubrey Almeida, MD How to Deal with Complications — Tomislav Mihaljevic, MD How to Apply to Myxomatous Diseases — Rakesh Suri, MD Vuyisile Nkomo, MD, Luc Pierard, MD, PhD Gregory Fontana, MD, Kevin Greason MD, Ehud Raanani, MD, Lars Svensson, MD Chair: A. Jamil Tajik, MD Trends in Rheumatic Valvular Heart Disease: A Longitudinal Study of Hospitalizations and the Effect of Immigration in New York City (1983-2007) — Martin Detchkov, BS Outcome of Mitral Valve Surgery in West African Patients — Enrico Donegani, MD Is 3D-echo Planimetry More Accurate than Bidimensionnel Echocardiography to Measure the Mitral Valve Area in Rheumatic Mitral Stenosis? — Soraya Benyoussef, MD Right Ventricular Dysfunction in Mild Mitral Stenosis — Wafa Fehri, MD Chair: Mark Starling, MD Thromboembolic Complications after Correction of Mitral Regurgitation: Our experience at the University Hospital of Bologna — Antonio Russo, MD Prognostic Value of Nonsustained Ventricular Tachycardia and Systolic Dysfunction after Surgery for Non-Ischemic Mitral Regurgitation — Oladipupo Olafiranye, MD Identification of Novel Mechanisms Contributing to Myxomatous Mitral Valve Disease — Michael A. Hagler, BS Preoperative Exercise Capacity Best Predicts Survival after Surgery for Chronic Nonischemic Mitral Regurgitation — Monica Diaz, BS The Mitral Regurgitation Severity Index: A Novel Spectral Doppler-based Echocardiographic Index for Severe Mitral Regurgitation — Ashraf Mostafa, MD Chair: Jacek Preibisz, MD Mitral Annular Dynamics in Functional Mitral Regurgitation: New Insights with Real-time 3-dimensional Echocardiography — Yan Topilsky, MD Papillary Muscle Dynamics in Functional Mitral Regurgitation: New Insights with Real-time 3-Dimensional Echocardiography — Yan Topilsky, MD Mid-term Results of Surgical Relocation of Papillary Muscles in Ischemic Mitral Regurgitation Due to Severe Mitral Tethering — Sachiko Yamazaki, MD Ventricular Approach for Severe Ischemic Mitral Regurgitation: Papillary Muscle Approximation through Left Ventriculotomy — Kenji Minakata, MD The Appraisal of Early Surgical Intervention for Mitral Regurgitation: Review of Twenty-year Experience of Mitral Valve Repair for Mitral Regurgitation — Takashi Murashita, MD Chair: Louis Salciccioli, MD Seven Years of Chordal Cutting in Ischemic Mitral Regurgitation — Davide Di Lazzaro, MD Vasodilator Drugs May Worsen Clinical Outcomes in Patients with Chronic Severe Mitral Regurgitation without Systolic Hypertension — Ofek Y. Hai, MD The Relationship Between the Magnitude of Reduction in Functional Mitral Regurgitation (MR) Severity and NYHA Functional Class Post-Treatment with the MitraClip Device — Paul Grayburn, MD The EVEREST II Randomized Clinical Trial (RCT): Three Year MitraClip Therapy Outcomes Classified by Degenerative or Functional Mitral Regurgitation Etiology — Ted Feldman, MD Chair: Eric Jamieson, MD Aortic and Mitral Regurgitation in a Patient with Possible IgG4-related Inflammatory Aortitis — Sanjay Kumar, MD Redo Aortic Valve and Root Replacement in the Young Adult — John L. Lamberti, MD Aortic Root Replacement After the Damus-Kaye-Stansel Procedure — John L. Lamberti, MD Making Sense of Aortic Valve Vegetations and B-Symptoms — Rachel J. Le, MD First-in-Man Implantation of a New 3-D Annuloplasty Ring for Repair of Aortic Valve Regurgitation — Domenico Mazzitelli, MD Stuck Mechanical Aortic Valve Evaluated by Four-dimensional Computed Tomography — Satoshi Numata, MD Chair: Warren Laskey, MD AVR for Severe AS in the Setting of AL Amyloidosis — Justin D. Roberts, MD Two to One: Congenitally Bicuspid Aortic Valve with Commissural Fusion Causing a Functionally Unicuspid Aortic Valve — Seth H. Sheldon, MD Structural Valve Degeneration 5 Years After Transapical TAVI — Marie-Elisabeth Stelzmuller, MD 5th Time Sternal Entry as a Mini-sternotomy for Reoperative Aortic Valve Replacement — Sreekumar Subramanian, MD Ruptured Aortic Root Dissection After Aortic Valve Replacement — Yoshikazu Suzuki, MD Sutureless Aortic Valve Replacement in a Patient with a Homograft Root — Michael Szczeklik, MD Chair: Allan Schwartz, MD Reoperative Aortic Root + Total Arch Replacement for Chronic Aneurysmal Dissection Post Type A Repair — Prashanth Vallabhajosyul, MD Primary Valve Repair with Root Reimplantation in Bicuspid Aortic Valve Disease — Prashanth Vallabhajosyul, MD Restoration of Severe Aortic Regurgitation with Sinus Valsalva (SOV) Aneurysm and Coronary Arterial Disease (CAD) — Yongin L. Kim, MD Simultaneous Transfemoral Transcatheter Aortic Valve Replacement and Abdominal Surgery for Symptomatic Aortic Valve Stenosis and Spleen Cancer — Veronica Bona, MD Stentless Bioprosthesis Dysfunction Mimicking Endocarditis — Davide DiLazzaro, MD Immediate Improvement in Mitral Regurgitation After Successful Transcatheter Aortic Valve implantation — Sorin Pislaru, MD, PhD 10:00 - 10:30 am
Break
10:30 - Noon
Co-chairs: Cary W. Akins, MD, Trevor Fayers, FRACS Functional Mitral Regurgitation: Quantitation – Outcome — Paul Grayburn, MD 3D-Echo in Ischemic Mitral Regurgitation — Joseph Maalouf, MD Ischemic Mitral Regurgitation Treatment: How Not to be Disappointed — Robert Klautz, MD Tricuspid regurgitation: New Insights into Natural History — Judy Hung, MD Tricuspid regurgitation: What to Do and When — Gilles Dreyfus, MD Panel Discussion/Q&A Co-Chairs: Linda Gillam, MD, Alfredo Trento, MD 3D for Mitral Repair — Alain Berrebi, MD 3D for Sapien Valves — Linda Gillam, MD 3D for Corevalve Procedures — Arsene Basmadjian, MD 3D for Mitral Percutaneous Procedures — David Messikka-Zeitoun, MD, PhD Co-Chairs: Raj Makkar, MD, Paul Sorajja, MD Annular Rupture — Samir Kapadia, MD Complications of Trans-Septal Approaches — Saibal Kar, MD Complication of Trans-Aortic Approach — Domenico Mazzitelli, MD Complication of Periprosthetic Regurgitation Closure — Paul Sorajja, MD Co-Chairs: Lieng Hsi Ling, MD, Charles Mack, MD, Ehud Raanani, MD Maze or no Maze for Paroxysmal AF — James Gammie, MD Right-Sided Maze for TR Surgery — Kenton Zehr, MD Ablation of AFib Post-Op — Peter Brady, MD Maze for Mitral Valve Diseases — Ehud Raanani, MD Rebecca Hahn, MD, Maurice E. Sarano, MD Michael A. Borger, MD, Gino Gerosa, MD, Rakesh Suri, MD Noon - 1:25 pm
Lunch
Symposia -- Supported by Abbott, Medtronic
1:30 - 3:00 pm
A Surgeon is the Best Interventional Valvular Therapist Co-chairs:Gregory Fontana, MD, O. Wayne Isom, MD Pro — Georg Lutter, MD A Bioprothesis is Preferred for Aortic Valve Regurgitation in a 55-Year-Old Man Co-chairs: Joseph Maalouf, MD, Allan Schwartz, MD Pro — W. Randolph Chitwood, MD Co-chairs: Raja Parvez Akhtar, MD, Vuyisile Nkomo, MD A. Sampath Kumar, MCh, Phyllis Supino, EdD An Illuminating Case from North Africa — Soraya Benyoussef, MD An Illuminating Case from the Middle East — Gad Keren, MD An Illuminating Case from Korea — Yong-Jin Kim, MD, PhD An Illuminating Case from Australia — Trevor Fayers, FRACS An Illuminating Case from South-Africa — Johan Brink, MD Co-chairs: Blase A. Carabello, MD, Robert Emery, MD New Anticoagulants — Stuart J. Connolly, MD Bleedings and The Von-Willebrandt Protein — Thierry Le Tourneau, MD Developing prostheses with low thrombotic risks — Manny Villafaña Co-chairs: Michel Pellerin, MD, José-Luis Pomar, MD Mitral Rings for Functional MR — David Adams, MD Mitral Rings for Myxomatous Disease — Patrick McCarthy, MD Adjustable Annuloplasty Rings — Joerg Seeburger, MD Choosing a Mitral Annuloplasty Ring — Cary W. Akins, MD What to Do With a Calcified Mitral Ring — Stephen K. Ball, MD Hector Michelena, MD, Kiyoshi Yoshida, MD, PhD, Cheuk-Man Yu, MD Marco Barbanti, MD, Ted Feldman, MD, Saibal Kar, MD 3:00 - 3:30 pm
Break
3:30 - 5:00 pm
Co-chairs:Carlos Ruiz, MD, Kenton Zehr, MD Aortic Valve Replacement After Coronary Artery Bypass Graft — Matthew R. Williams, MD Redo Valve Repair — Jean-François Obadia, MD Aortic Valve in Valve — Josep Rodes-Cabau, MD Mitral Valve in Ring or in Valve — Michael A. Borger, MD Periprosthetic Regurgitation — Chet Rihal, MD Panel Discussion/Q&A Co-chairs: Jeffrey S. Borer, MD, Gregg W. Stone, MD Medical Device Regulatory Essentials — Bram Zuckerman, MD Issues in Clinical Trial Design for Transcatheter Valves — Julie Swain, MD It's Not All About the Pivotal Study: FDA's Perspective on How to Get to First-In-Human Studies and Beyond — Sonna Patel, PhD Co-chairs: Adrian Chester, PhD, David Messika-Zeitoun, MD, Jordan Miller, PhD Targeting Information to Slow Progression of CAVD — Elena Aikawa, MD High Throughput Identification of Novel Targets in CAVD — Patrick Mathieu, MD Transgenic Mice Models of CAVD — Jordan Miller, PhD Co-chairs: Eric E. Roselli, MD, Johanna J.M. Takkenberg, MD, PhD Bioprostheses with Thrombosis: Does That Exist? — Joseph Bavaria, MD This New Bioprosthesis is Much Better — Eric Jamieson, MD This New Bioprosthesis is Even Better — Yukikatsu Okada, MD Better? Are You Sure? — Johanna J.M. Takkenberg, MD, PhD Marcia Barbosa, MD, Patrizio Lancellotti, MD, PhD, Sunil Mankad, MD Co-chairs: Johan Brink, MD, Jagat Narula, MD, Vuyisile Nkomo, MD, Elijah Nyainda Ogola, MD Presenters: Raja Parvez Akhtar, MD, Soraya Benyoussef, MD, Jeswant Dillon, MD, A. Sampath Kumar, MCh Chair:A. Jamil Tajik, MD Hemodynamic Profile of the Mitroflow Aortic Pericardial Prosthesis Up to Five Years After Implantation: Follow Up from the North American Prospective Multi-center Study — Federico M. Asch, MD Comprehensive Hemodynamic Evaluation and Early Performance of the St. Jude Medical Trifecta Aortic Valve Tissue Prosthesis — Gabriel Vorobiof, MD Transcatheter Aortic-Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results of the Global Valve in Valve Registry — Danny Dvir, MD The Optimum Transcatheter Aortic Valve — Mano J. Thubrikar, MD Is Euroscore II More Suitable in Patients with Low Ejection Fraction to Assess Operative Mortality Risk? Results in a Cohort of 3507 Patients who Underwent Biological Aortic Valve Replacement (BAVR) between 2002 and 2010 — Jean Christian Roussel, MD Chair: Mark Starling, MD Posttraumatic Stress Disorder in Patients with Mitral Regurgitation: The Effect on Somatic Manifestations and Health Related Quality of Life — Tali Topilsky, MD Minimally Invasive versus Median Sternotomy Aortic Valve Replacement: Outcomes and Health-Related Quality of Life — Alan Speir, MD Health-Related Quality of Life Following Isolated Aortic Valve Surgery — Niv Ad, MD Improving the Quality of Life in Valvular Heart Disease : Role of Novel Herbal Procedure 'Sampurna Hridaya Shuddhikaran'[SHS] — Rohit Sane, MD Chair: Phyllis Supino, EdD The Epidemiology of Valvular Heart Diseases: Incidence Growing — Phyllis Supino, EdD Impact of Co-existing Coronary Disease on In-hospital Mortality of Patients with Valvular Heart Disease in New York State (1983-2007) — Ofek Y. Hai, DO Posttraumatic Stress Disorder in Patients Treated with Traditional vs. Minimally Invasive Repair or Conservatively for Chronic Mitral Regurgitation: A Prospective Study — Tali Topilsky, MD Women Have Greater Mid-term Quality of Life Benefit than Men After Valvular Surgery — Phyllis Supino, EdD Prevalence of Non-Coronary Structural Heart Abnormalities in a Black Inner City Population — Sanjay Kumar, MD Chair: Adam Budzikowski, MD Left Atrial Contractile Function Following a Successful Modified Maze Procedure at Surgery and the Risk for Subsequent Thromboembolic Stroke — Rafael Kuperstein, MD Preoperative Atrial Fibrillation Predicts Outcome after Valve Repair for Mitral Valve Prolapsed — Christophe Tribouilloy, MD Outcomes of the Cox Maze Procedure in Patients Undergoing Aortic Valve or Aortic Valve Plus CABG Procedures — Niv Ad, MD Incidence of Post-Operative Atrial Fibrillation in Patients Undergoing Minimally Invasive Valve Surgery — Christos G. Mihos, DO Valvular Regurgitations Associated with Atrial Fibrillation: A Community Based Study — Ori Vatury, MD An Effective Modification To Simplify The Right Atrial Lesion Set of the Cox CryoMaze — Harold Roberts, MD Chair:A. Jami Tajik, MD Antiphospholipid Antibody-Associated Mitral Valve Endocarditis and Regurgitation Successfully Treated with Medical Therapy — Tahmeed Contractor, MD Multi Imaging Diagnosis of Severe Mitral Regurgitation and Dilated Cardiomyopathy Due to a Rare Congenital Malformation: Gigantic Circumflex Coronary Artery — Giovanna Di Giannuario, MD Transcatheter Transvenous Valve-in-Valve Implantation for Severe Mitral Bioprosthetic Stenosis — Oluseun O. Alli, MD Mitral Valve Reconstruction for Recurrent Mitral Regurgitation Seven Years After Mitral Valve Repair Due to Isolated Post-ischemic Papillary Muscle Dysfunction — Abdul-Hakim Dayeh, MD Severe Mitral Stenosis with Pulmonary Hypertension: Or Is It? The Great Mimicker — Arsene J. Basmadijian, MD Redux of Ischemic Mitral Repair by Leaflet Extension with Autologous Pericardium — Gheorghe Cerin, MD Chair:Leland Siwek, MD Repair of Radiation-induced Mitral Regurgitation by Posterior Leaflet Extension — Gheorghe Cerin, MD Surgical Management of Systolic Anterior Motion After Previous Mitral Valve Repair — Murtaza Dawood, MD Ring on Ring - Reoperative Technique for Recurrent Mitral Regurgitation After Prior Repair — Murtaza Dawood, MD Facile Approach to Neochordal Placement for Complex Mitral Valve Regurgitation — Michael J. Del Rio, MD Exercise-induced Change in Severe Mitral Regurgitation in an Asymptomatic Patient with Myxomatous Bileaflet Valve Prolapsed — Haifa Mahjoub, MD Papillary Muscle Rupture in Myocardial Infarction — Muhammad F. Jan, MD Chair:Amanda Rhee, MD Re-Redo Mitral Valve Repair — Useful or Even Possible — A Case Report — Denise Marin, MD Regional Myocardial Dysynchrony Causing Mitral Regurgitation (MR) and Heart Failure (HF) — Sridhar Reddy Musuku, MD Re-repair for Recurrent Mitral Regurgitation Using a Glutaraldehyde-treated Autologous pericardium — Yukikatsu Okada, MD Acute Ischemic Heart Failure and False Mitral 'Prolapse' Due to Papillary Muscle elongation — Bogdan Adrian Popa, MD Mitral Leaflet Perforation Due to Severe Mitral Annular Calcification (MAC) — Pablo Rengifo-Moreno, MD Saturday, April 14, 20127:00 - 8:25 am
Continental breakfast
7:30 - 10:00 am
Co-chairs: Cary W. Akins, MD, Friedrich W. Mohr, MD, PhD, Jean-François Obadia, MD, Yukikatsu Okada, MD, Hartzell Schaff, MD, Joerg Seeburger, MD P2 Flail Repair — Trevor Fayers, FRACS A2 Flail Repair — Joseph Bavaria, MD Commissural Prolapse Repair — Kenton Zehr, MD How Much to Resect — José-Luis Pomar, MD Adjusting Artificial Chords — Aubrey Almeida, MD Adjusting Annuloplasty for Ischemic MR — Antonio Maria Calafiore, MD Adjusting Annuloplasty for Myxomatous Disease — Patrick McCarthy, MD Ischemic MR Treated Thoracoscopically — Clark Hargrove, MD Preventing SAM — Didier Loulmet, MD A Simple Repair and Maze Case — Jean-François Obadia, MD Co-chairs: Judy Hung, MD, Gad Keren, MD, Luc Pierard, MD, PhD, Maurice E. Sarano, MD, Andrew Wang, MD A 3D View of the Lesions — Joseph Maalouf, MD How Do You Catch This Mitral Valve in 3D? — Arsene Basmadjian, MD Asymptomatic AS with Elevated BNP? — Jutta Bergler-Klein, MD Pregnancy in Valve Diseases — Uri Elkayam, MD Pulmonary Edema: Is It a Valve Disease? — Patrizio Lancellotti, MD, PhD Flail or Not Flail? — Lieng Hsi Ling, MD End-Systolic MR — Salvatore Costa, MD The MR Disappeared with BiV Pacing — Cheuk-Man Yu, MD How severe is the TR? — Hector Michelena, MD TR, Is It the Pacemaker? — Vuysile Nkomo, MD Asymptomatic MR with Elevated BNP? — Rodolfo Pizarro, MD Co-chairs: Ted Feldman, MD, Carlos Ruiz, MD, James Slater, MD, Murat Tuzcu, MD TAVI for Low-Risk Patient — Marco Barbanti, MD A Simple Apical Approach — Kevin Greason, MD A Fragile Apex for TAVI — Eric E. Roselli, MD Deploy This Valve – How to? — Susheel Kodali, MD Mitral Balloon Valvuloplasty — Igor Palacios, MD Totally Percutaneous TAVI? — Josep Rodes-Cabau, MD How to Deploy with Complete Annular Calcifications — Thoralf Sundt, MD How to Deploy TAVI with Severe Anterior Leaflet Calcification — Samir Kapadia, MD How to Avoid Stroke? — Gregory Fontana, MD Clip or repair — Alfredo Trento, MD 7:30 – 10:30 am
Chair:Edmund Herrold, MD, PhD Prognostic Implication of BNP Levels in Patients Who Underwent Surgery for Degenerative Mitral Regurgitation — Rodolfo Pizarro, MD Where Leaks in the Ischemic Mitral Regurgitation? — Zhaoming He, MD Multi Imaging Diagnosis of Severe Mitral Regurgitation and Dilated Cardiomyopathy Due to a Rare Congenital Malformation: Giant Circumflex Coronary Artery Draining to the Coronary Sinus — Giovanna Di Giannuario, MD Direct Quantification of Mitral Regurgitation Flow Volume by Single-beat Real Time 3-dimensional (RT3D) TTE — Sung-Ji Park, MD, PhD BREAK (15 min) Chair:Edmund Herrold, MD, PhD The Tricuspid Valve Also Has a Ventricle — Ulrik Hvass, MD Functional Tricuspid Regurgitation Repair with a Three-dimensional Design Ring: Short and Mid-term Results — Emilio Monguio, MD Carpentier-Edwards Physio Tricuspid Annuloplasty Ring: Preliminary Results of A New Selectively Flexible Three Dimensional Ring for Tricuspid Valve Repair — Faisal H. Cheema, MD Ischemic Mitral Regurgitation Contributes to Alterations in Three-Dimensional Intracardiac Flow Patterns — Melissa M. Levack, MD, PhD Three-Dimensional Color Doppler Echocardiography versus Two-Dimensional Derived Method in the Quantification of Tricuspid Regurgitation Orifice Area — Tien-En Chen, MD Chair:Blase Carabello, MD Concurrent Mitral and Tricuspid Valve Intervention Via a Minimally Invasive Approach is Safe and Effective — Sophie Jones, MD Papillary Muscles Relocation Stitches – What are the Cyclic Tension Alterations Imposed on the Myocardium? — Henrik Jensen, MD The Outcomes of Triple Valve Surgery, 11 Year Experience — Nicholas Nikolaidis, MD End Stage Valvular Heart Disease treated successfully with Double Valve Replacement — Virendar Sarwal, MD Parasternal Approach for Multi-Valve Surgery — Pei-Fen Lin, RN BREAK 15 min. Chair:Adam Budkizowski, MD Impact of 3D Hi Vision Endoscopy in Minimally Invasive Mitral Valve Surgery — Masahiko Kuinose, MD Should a Mitral Valve Annuloplasty Always Be Performed During Ventricular Reduction Operations: A 16 Year Experience — Steven R. Gundry, MD Bi-leaflet Mechanical Prostheses are Suitable for a Majority of Rheumatic Mitral Valve Patients in a Developing Country — Johan Brink, MD Assessment of Mitral Valve and Left Ventricular Geometry after Surgical Repair of Submitral Left Ventricular Aneurysms with Multi-Slice Computed Tomography — Adam J. Penkalla, MD Discharge Patterns for Patients Undergoing Totally Endoscopic Robotic Mitral Valvuloplasty: Does Surgeon Experience Translate into Early Discharge? — Faisal H. Cheema, MD Chair:Adrian Chester, PhD Adipose Derived-Stem Cells As Source Of Endothelial Cells For Cardiac Tissue Engineering — Pamela Somers, MD A Small Animal Model of Accelerated Cardiovascular Calcification to Evaluate Biological versus Tissue-engineered Heart Valve Prostheses — Alexander Assmann, MD Persistent Fibronectin Coating Induces Recellularization of Tissue-engineered Aortic Conduits in a Small Animal Model — Alexander Assmann, MD Translational Personalized Regenerative Medicine: Scaffolds and Stem Cells for Patient-Tailored Aortic Heart Valve Tissue Engineering — Dan T. Simionescu, PhD MK-886 (5-lipoxigenase inhibitor) and DITPA (thyroid hormone analog ) Attenuate Global Myocardial Ischemia Reperfusion Injury after Heterotopic Heart Transplantation in Male Rats — Fadhi Ghaly Yousif Al-Amran, MD Amelioration of Heart Transplantation – Induced Ischemia Reperfusion Injury by Melatonin and Ghrelin in Rats — Najah R. Hadi, PhD BREAK 15 minutes Chair:Michael Augenbraun, MD Infective Endocarditis in Mitral Valve Prolapse: A Function of Mitral Regurgitation? — Ognjen Katan, MD Results of the "No-React®" Bioprosthesis in Patients with Active Infective Endocarditis: 11-Year Single Center Experience in 402 Patients — Michele Musci, MD 11 Years of Experience in Endocarditis Surgery from a Single Centre; Early and Late Outcome Results — Ryan Perera, MD Incidence of Infective Endocarditis Due to Viridans Group Streptococci: Impact of the 2007 American Heart Association's Endocarditis Prevention Guidelines — Daniel C. DeSimone, MD Double Valve Replacement and Intervalvular Fibrous Body Reconstruction in Patients with Infective Endocarditis — Piroze A. Davierwala, MD Chair:Judith Mitchell, MD Pre-operative Left Ventricular Size and Function Predict Outcome After Minimally-invasive Mitral Valve Replacement in Patients with Advanced Heart Failure — Evan Brittain, MD Risk Analysis for Patients Undergoing Mitral Valve Surgery — Michelle D. Shen, MD Effect of Mitral Ring Flexibility on Chordal Force Balance and Mitral Annular Geometry — Jesper L. Honge, MD Concomitant Robotic Mitral and Tricuspid Repair: An Early Experience — Clifton T.P. Lewis, MD Percutaneous Edge-to-edge Mitral Valve in High-risk Patients: Results from a Real World Setting — Valleria Cammalleri, MD BREAK 15 minutes Chair:Judith Mitchell, MD Visualization of Submitral Structure by 3D Transgastric Echocardiography — Kikuko Obase, MD New Technique for Correction of Anterior Leaflet Prolase — Ignacio Moriones, MD 3D-Rotational Angiography (Dyna-CT) Supports MitraClip Implantation — Philipp Kiefer, MD 3D-Rotational Angiography (Dyna-CT) for Mitral Valve Imaging in an Acute Animal Model — Thilo Noack, MD "Loop-in-Loop technique" for Multiple PTFE Neo-chordae Creations in Mitral Valve Chair:Emmanuel Lansac, MD Between Scylla and Charybdis — Muhammad F. Jan, MD Rupture of Mitral Valve Leaflet Due to Large Endocarditis — Sanjay Kumar, MD Recurrent Non-bacterial Thrombotic Endocarditis Following Bioprosthetic Mitral Valve Replacement — Dawn C. Scantlebury, MD Management of Hemopericardium as a Complication of Mitral Balloon Valvuloplasty for Mitral Stenosis — Jeremy Steele, MD Mitral Valve Perforation by "Banging Mechanism" of Isolated Aortic Valve Vegetation — Yoshikazu Suzuki, MD Role of Intraoperative TEE in Defining the Transmitral Inflow Velocity Profile Across the Side Stream of Mechanical Valve Leaflet Orifice. A Novel Finding in The Settings of Postcardiotomy Tamponade — Maqsood Elahi, MD 15 minute break Chair:Taweesak Chotvantanapong, MD Missed Unroofed Coronary Sinus in an Adult Patient: When Simple Closure of a Secundum Atrial Septal Defect is not Enough — Ahmed M. El-Eshmawi, MD Surgery for Active Infective Endocarditis with Submitral Abscess and Annular Calcification — Kazuyuki Daituku, MD Minimally Invasive Surgical Resection of Aortic and Mitral Valve Fibroelastoma Tumors — Elie M. Elmann, MD Innovative Approach in Ischemic Mitral Regurgitation: Posterior Mitral Leaflet Extension by Triangular Pericardial Patch — Marco Diena, MD Chair:Sary Aranki, MD Resistant Hypoxemia in Untreated Ebstein Anomaly — Zeeshan A. Khan, MD Carcinoid Heart Disease — Sameer Chadha, MD Thrombosis or Endocarditis? — Miroslava Benesova, MD Invasive Thymoma: Intracaval Invasion and Extension into the Right Ventricle — Sameer Chadha, MD The Saga of a Hole — Muhammad F. Jan, MD Exam and Echocardiographic Similes in Severe TR — Muhammad F. Jan, MD Chair:Jeswant Dillon, MD Trimodality Management In Left and Right Sided Endocarditis — Hardip Singh, MD Prosthetic Valve Challenges and Multimodality Imaging — Matthew Schmidt, MD Improved Outcome with Mitral Repair and AF ablation in a Patient with Severe LV Dysfunction in Dilated Cardiomyopathy — Maurizio Taramasso, MD Unusual Cause of Stroke in a Young Woman — Elijah N. Ogola, MD Mitral Valve Stenosis Due to Supravalvular Pannus Formation After Mitral Valve Repair — Murtaza Dawood, MD A Case for Salvage Valve Surgery in Medically Complex Dilated Cardiomyopathy — Punit K. Sarna, MD 10:00 - 10:30 am
Refreshments with continued session
10:30 - Noon
Co-chairs: Trevor Fayers, FRACS, Clifton Lewis, MD, Francesco Musumeci, MD, Yutaka Okita, MD, PhD, Ehud Raanani, MD Extensive Myxomatous Valves — David Adams, MD Endocarditic MRW — Randolph Chitwood, MD Calcified Rheumatic MR — Taweesak Chotivatanapong, MD Is That AR Repairable? — Gebrine El-Khoury, MD How to Support the Aortic Annulus for Repair — Emmanuel Lansac, MD, PhD Double Repair Mitral and Aortic — Tomislav Mihaljevic, MD Double Repair Mitral and Tricuspid — Michel Pellerin, MD My Toughest Robotic Repair — Rakesh Suri, MD Co-chairs: Jeffrey S. Borer, MD, Yong-Jin Kim, MD, PhD, Rodolfo Pizarro, MD, Jean-Louis Vanoverschelde, MD, PhD, Kiyoshi Yoshida, MD, PhD An Old Man with MR: What to Do? — Bernard Iung, MD Is that Chagas Disease with MR? — Marcia Barbosa, MD, PhD Post-Clip Recurrent MR — Elyse Foster, MD Imaging Post-Radiation Valve Disease — Paul Grayburn, MD Post-TAVI AR — Rebecca Hahn, MD A Familial AS — Thierry Le Tourneau, MD Is That Severe AS? — Raphael Rosenhek, MD A 3D View of the TR — Sunil Mankad, MD Co-chairs: Igor Palacios, MD Josep Rodes-Cabau, MD, Eric E. Roselli, MD, Thoralf Sundt, MD A difficult Valve in Valve — Michael A. Borger, MD Clipping MR Due to AFib — Ted Feldman, MD Clipping Functional MR with LV Dysfunction — Saibal Kar, MD TransApical Mitral Intervention — Georg Lutter, MD TAVI for Post-Radiation Heart Disease — Raj Makkar, MD TransAortic TAVI — Domenico Mazzitelli, MD TransApical Preiprosthetic Plugging — Carlos Ruiz, MD TransAxillary TAVI — Murat Tuzcu, MD Chair:James Slater, MD Mitral Valve Repair: The Trans-Atlantic Correction — Mark J. Cunningham, MD Three Years Follow-up of Repaired Barlow Mitral Valves via Right Minithoracotomy vs. Median Sternotomy — Giuseppe Nasso, MD Long-term Results of Isolated Mitral Valve Replacement with a Biocor Porcine Valve — Tomaso Bottio, MD Tricuspid Annuloplasty for Functional Tricuspid Regurgitation in Patients Undergoing Mitral Valve Repair for Chronic Severe Mitral Regurgitation — Yukikatsu Okada, MD Video-Thoracoscopic Minimally Invasive Mitral Valve Repair Without Patients Selection: Operative Results — Giovanni Domenico Cresce, MD, PhD Chair:Mark Starling, MD Calcification of the Mitral Valve and Annulus in Dialysis Patients: Systematic Evaluation of Effects on Valve Anatomy and Function — Rajesh Movva, MD Reduced Lysyl Oxidase Expression is Associated with Altered Collagen Deposition in Degenerative Mitral Valve Disease — Meerarani Purushothaman, MD Chordal Rupture is Associated with Altered Extracellular Matrix Architecture and Valvular Interstitial Cell Content in Degenerative Mitral Valve Disease — Purushothaman K-Raman, MD Impact of Gender on Contractile Behaviour of Skinned Papillary Muscle of Female and Male Patients with Mucopolysaccharidosis — Constanze Bening, MD Valve Replacement and Repair in Patients with Mucopolysaccharidoses — Lennart F. Duebener, MD Chair:Edmund Herrold, MD, PhD Factors Influencing Natural Course of Congenital Aortic Stenosis in Young Adults: A Multicenter Study — Denise van der Linde, MD Preoperative Left Ventricular Function in Degenerative Mitral Valve Disease — Gleb Kim Left Ventricular Outflow Tract Dynamics: A 3D Transesophageal Echocardiographic Study — Mariano L. Falconi, MD Experimental Evaluation of a New Apical Access and Closure Device — Johannes Blumenstein, MD Left Heart Valve Replacement with Mechanical Prostheses in West African Adolescents. A 6-year Retrospective Study — Enrico Donegani, MD Chair:Erdal Cavusoglu, MD Outcome of Aortic Valve and/or Root Replacement with Stentless Bioprothesis in Guch Patients — Guido Michielon, MD Thrombosis of St. Jude Medical Epic™ Bioprostheses, and Complete Resolution on Recommencement of Oral Anticoagulation — Peter D. Ogutu, MD Will Minimally Invasive Valve Surgery Become the Total Solution? — FEMH Experience — Chen-Fen Tsai, RN Mitral Valve Repair Can Delay Referral for Cardiac Transplantation — Punit K. Sarna, MD Severe Symptomatic Left Ventricular Inflow Obstruction After Mitral Annuloplasty Ring — an Observation — Muhammad F. Jan, MD Noon
Adjourn
Participants submit CME forms Note: Attendees must fill out online evaluation form to receive CME credits. Evaluation link: https://www.surveymonkey.com/s/hvsa2012
* Space limited. Once you've registered, send an email with the subject line "3D Cropping Class" to info@heartvalveconference.com with your name and registration number. ** Space limited. Once you've registered, send an email with the subject line "Robot Manipulation Class to info@heartvalveconference.com with your name and registration number. |
 |
||||||||||||
